-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The production process of 5-pyrimidinemethanol is a complex and multi-step process that involves several chemical reactions and purifications.
It is an important chemical intermediate in the pharmaceutical industry, used in the production of several drugs and other pharmaceutical products.
The production process of 5-pyrimidinemethanol can be broken down into the following steps:
- Preparation of the starting material: The production process of 5-pyrimidinemethanol begins with the preparation of the starting material, which is typically 2,6-dimethylphenol.
This material is synthesized through a multi-step process involving the reaction of phenol with dimethyl sulfate and subsequent hydrolysis. - Hydroxylation: The next step in the production process is hydroxylation, where 2,6-dimethylphenol is treated with a strong oxidizing agent such as osmium tetroxide or chromium(VI) oxide in the presence of a catalyst such as sodium hydroxide.
This reaction converts the double bond in 2,6-dimethylphenol to a hydroxyl group, resulting in the formation of 2,6-dimethyl-2,5-pyrrolidine-diol. - Ring-closing metathesis: In the next step, the double bond in the 2,6-dimethyl-2,5-pyrrolidine-diol is reduced using a metal catalyst such as ruthenium or molybdenum halides.
This results in the formation of 5-methyl-2,4-dioxo-3-furancarboxylate. - Nitration: The 5-methyl-2,4-dioxo-3-furancarboxylate is then treated with nitric acid to introduce a nitro group.
This results in the formation of 5-methyl-2,4-dioxo-3-furanonitrile. - Reduction: The nitro group in the 5-methyl-2,4-dioxo-3-furanonitrile is reduced using a reducing agent such as lithium aluminum hydride or hydrogen in the presence of a catalyst such as palladium on barium oxide.
This results in the formation of 5-methyl-2,4-dioxo-3-furancarboxylate. - Halogenation: The 5-methyl-2,4-dioxo-3-furancarboxylate is then treated with a halogenating agent such as chlorine or bromine in the presence of a catalyst such as pyridine.
This results in the formation of 5-methyl-2,4-dioxo-3-furan-2-yl chloride or bromide. - Dehydrogenation: The final step in the production process is dehydrogenation, where the 5-methyl-2,4-dioxo-3-furan-2-yl chloride or bromide is treated with a dehydrogenating agent such as potassium permanganate or sodium.
This results in the formation of 5-methyl-2,4-dioxo-3-furan-2-ol, also known as 5-pyrimidinemethanol.
Overall, the production process of 5-pyrimidinemethanol involves multiple chemical reactions and purifications, and requires the use of specialized equipment and chemical handling procedures.
The process is carried out in a well-ventilated area by trained personnel wearing appropriate protective gear.
The purity of the final product is analyzed using various chemical and spectroscopic techniques to ensure that it meets the required specifications for pharma